160 related articles for article (PubMed ID: 12537982)
1. Masked MLL gene rearrangement was disclosed in the clinical course and sequential development of chromosome abnormality in a patient with therapy related acute myelogenous leukemia.
Hashimoto S; Toba K; Izumi N; Sato N; Takahashi H; Ozawa T; Moriyama M; Aoki S; Furukawa T; Narita M; Takahashi M; Aizawa Y
Leuk Res; 2003 Mar; 27(3):285-90. PubMed ID: 12537982
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
3. MLL gene rearrangement in t(9;11) acute myelogenous leukemia with minimal myeloid differentiation (FAB subtype M0).
Shimoda K; Sugio Y; Miyahara M; Watanabe K; Tokunaga Y; Asano Y; Gondo H; Okamura T; Niho Y
Int J Hematol; 2000 Apr; 71(3):245-8. PubMed ID: 10846829
[TBL] [Abstract][Full Text] [Related]
4. Characterization of t(11;19)(q23;p13.3) by fluorescence in situ hybridization analysis in a pediatric patient with therapy-related acute myelogenous leukemia.
Cheng L; Ramesh KH; Radel E; Ratech H; Wei D; Cannizzaro LA
Cancer Genet Cytogenet; 2001 Aug; 129(1):17-22. PubMed ID: 11520560
[TBL] [Abstract][Full Text] [Related]
5. Secondary acute myelogenous leukemia with MLL gene rearrangement following radioimmunotherapy (RAIT) for non-Hodgkin's lymphoma.
Nabhan C; Peterson LA; Kent SA; Tallman MS; Dewald G; Multani P; Gordon LI
Leuk Lymphoma; 2002 Nov; 43(11):2145-9. PubMed ID: 12539741
[TBL] [Abstract][Full Text] [Related]
6. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
[TBL] [Abstract][Full Text] [Related]
7. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
[TBL] [Abstract][Full Text] [Related]
8. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
[TBL] [Abstract][Full Text] [Related]
10. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
[TBL] [Abstract][Full Text] [Related]
11. MLL rearrangement with t(6;11)(q15;q23) as a sole abnormality in a patient with de novo acute myeloid leukemia: conventional cytogenetics, FISH, and multicolor FISH analyses for detection of rare MLL-related chromosome abnormalities.
Park TS; Lee ST; Song J; Lee KA; Lee SG; Kim J; Suh B; Kim SJ; Lee JH; Park R; Choi JR
Cancer Genet Cytogenet; 2008 Nov; 187(1):50-3. PubMed ID: 18992643
[TBL] [Abstract][Full Text] [Related]
12. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
[TBL] [Abstract][Full Text] [Related]
13. Secondary acute myeloid leukemia with translocation (4;11) and MLL/AF4 rearrangement in a 15-year-old boy treated for common acute lymphoblastic leukemia 11 years earlier.
Blütters-Sawatzki R; Borkhardt A; Grathwohl J; Repp R; Rheinisch-Becker I; Bohle RM; Lampert F
Ann Hematol; 1995 Jan; 70(1):31-5. PubMed ID: 7827204
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related T cell lymphoblastic lymphoma with t(11;19)(q23;p13) and MLL gene rearrangement.
Thandla S; Alashari M; Green DM; Aplan PD
Leukemia; 1999 Dec; 13(12):2116-8. PubMed ID: 10602439
[No Abstract] [Full Text] [Related]
15. MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia.
Sugita K; Taki T; Hayashi Y; Shimaoka H; Kumazaki H; Inoue H; Konno Y; Taniwaki M; Kurosawa H; Eguchi M
Genes Chromosomes Cancer; 2000 Mar; 27(3):264-9. PubMed ID: 10679915
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J;
Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663
[TBL] [Abstract][Full Text] [Related]
17. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
[TBL] [Abstract][Full Text] [Related]
18. Late-appearing MLL rearrangement arising as a secondary change in adult acute myeloid leukemia.
Rowe D; Breese GJ; Lennard A; Bown N
Genes Chromosomes Cancer; 2002 May; 34(1):126-8. PubMed ID: 11921290
[TBL] [Abstract][Full Text] [Related]
19. Acute myelogenous leukemia with monosomy 7, inv(3) (q21q26), involving activated EVI 1 gene occurring after a complete remission of lymphoblastic lymphoma: a case report.
Igarashi T; Shimizu S; Morishita K; Ohtsu T; Itoh K; Minami H; Fujii H; Sasaki Y; Mukai K
Jpn J Clin Oncol; 1998 Nov; 28(11):688-95. PubMed ID: 9861236
[TBL] [Abstract][Full Text] [Related]
20. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.
Megonigal MD; Rappaport EF; Jones DH; Kim CS; Nowell PC; Lange BJ; Felix CA
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11583-8. PubMed ID: 9326653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
